122958-35-4

Upstream product

• 125228-86-6 N-<2-<4-(1H-imidazol-1-yl)phenoxy>ethyl>propanamide 
• 10041-02-8 p-imidazo-1-ylphenol 
• 870-24-6 2-chloroethanamine hydrochloride 

Downstream Products

• 128264-17-5 dicyclopropanemethanone (+/-)-O-<2-hydroxy-3-<<2-<4-(1H-imidazol-1-yl)phenoxy>ethyl>amino>propyl>oxime 
• 128264-19-7 N-[4-[2-Hydroxy-3-[[2-[4-(1H-imidazol-1-yl)phenoxy]ethyl]amino]propoxy]phenyl]methanesulfonamide hydrochloride 

Relevant academic research and scientific papers

Derivatized alkanolamines as cardiovascular agents

Novel derivatized alkanolamines of the following structural formula STR1 are described as useful cardiovascular agents. Most especially described is their usefulness as cardiovascular agents exhibiting an antiarrhythmic effect. Said antiarrhythmic effect is of a combination Class II/Class III variety. Pharmaceutical formulations containing such compounds are also described.

Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity

Several (aryloxy)propanolamines and related compounds (i.e. 5-13, 16-18, 20-24, 27-33, 35, 37-39, 41, and 42) were synthesized and investigated for their class III electrophysiological activity and class II (β-blocking) effects with use of in vitro and in

1-(4-Substituted phenyl)-1H-imidazoles compounds

Novel 1-(4-substituted phenyl)-1H-imidazoles and their use as antiarrhythmic, anti-hypertensive and anti-ischemic agents is described. Pharmaceutical formulations containing such compounds are also discussed.